Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2719 results

Sort By:

Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery

Study ID: NCT06348134
Start Date: 2026-01-01
End Date: 2036-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

74

Intervention / Treatment

Trastuzumab emtansine

Pertuzumab Injection

Docetaxel

Grind it into fine powder

Letrozole

Goserelin

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.

Study ID: NCT07086534
Start Date: 2025-12-15
End Date: 2031-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

GeminiOne Transcatheter Edge-to-Edge Repair (TEER) System

Sponsor

Sierra Valve LLC

Source: clinicaltrials.gov

Share:
Add to list

Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery

Study ID: NCT07115030
Start Date: 2026-01-10
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

532

Intervention / Treatment

PCT+2HOPE

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list

Predictive Factors of Response to Phase II Cardiac Rehabilitation in Heart Failure With Reduced Ejection Fraction

Study ID: NCT07164911
Start Date: 2025-11-03
End Date: 2027-11-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

62

Intervention / Treatment
Sponsor

Corbie Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris

Study ID: NCT06729450
Start Date: 2026-01-30
End Date: 2026-12-16
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

DispersinB Acne Cleanser

Sponsor

Kane Biotech Inc

Source: clinicaltrials.gov

Share:
Add to list

A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS

Study ID: NCT05497401
Start Date: 2026-04
End Date: 2028-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

MesenCure

Placebo

Sponsor

BonusBio Group Ltd

Source: clinicaltrials.gov

Share:
Add to list

Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)

Study ID: NCT07104812
Start Date: 2026-01
End Date: 2027-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

15

Intervention / Treatment

Osilodrostat 1 MG

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Development and Investigation of the ApneaTheraPlay

Study ID: NCT07214636
Start Date: 2025-12-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

54

Intervention / Treatment

Structured Pre-Sleep Exercise

ApneaTheraPlay (ATP)

Sponsor

Medipol University

Source: clinicaltrials.gov

Share:
Add to list

Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines

Study ID: NCT06676644
Start Date: 2025-11-05
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

adjuvanted

non-adjuvanted

Sponsor

National Taiwan University Hospital

Source: clinicaltrials.gov

Share:
Add to list

Safety Profile of Psilocybin for Cocaine Use Disorder

Study ID: NCT06102434
Start Date: 2025-12
End Date: 2026-06
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

10

Intervention / Treatment

Psilocybin

Sponsor

University of California, Los Angeles

Source: clinicaltrials.gov

Share:
Add to list